Corvidia Therapeutics

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Corteria

This biopharmaceutical company develops therapeutic drugs for patients with obesity and heart failure subpopulations.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Corteria Pharmaceuticals

This biopharmaceutical company develops first-in-class drugs for patients with heart failure subpopulations, obesity and autosomal dominant polycystic kidney disease.

ProCorde AG

This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.

Marea Therapeutics

This biotechnology company develops medicines for cardiometabolic and cardioendocrine diseases using human genetic data for patients with unmet medical needs.

Imbria

This clinical-stage biotechnology company develops novel therapies targeting cardiac energy metabolism for patients with serious cardiovascular and metabolic diseases.